-transparent.png){kind=logo}
From 9.1988 to 7.1989 we carried out on 50 patients at the Department of Gynaecology of the University of Freiburg a randomized double-blind study to compare the first dimeric, nonionic, hexaiodinated, water-soluble contrast agent (Iotrolan-300 corresponding to Isovist-300) with a nonionic, monomeric preparation (Iopamidol-300 corresponding to Solutrast-300) using the concentration of 300 mg I/ml. Both medicaments show a high contrast quality in the X-rays. Complications like hypersensitivity reactions resp. actual local irritations were not recorded. Iotrolan-300 was found to be the best tolerated of the two contrast media in respect of mildest intensity of pain.
Related Publications
R Schulz-Wendtland, and
M Bauer, and
K W Henne
January 1988,
The British journal of radiology,
R Schulz-Wendtland, and
M Bauer, and
K W Henne
May 1994,
Radiology,
R Schulz-Wendtland, and
M Bauer, and
K W Henne
August 1992,
Der Radiologe,
R Schulz-Wendtland, and
M Bauer, and
K W Henne
October 1988,
The British journal of radiology,
R Schulz-Wendtland, and
M Bauer, and
K W Henne
August 1995,
Radiology,
R Schulz-Wendtland, and
M Bauer, and
K W Henne
September 1993,
Aktuelle Radiologie,
R Schulz-Wendtland, and
M Bauer, and
K W Henne
February 1991,
RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin,
R Schulz-Wendtland, and
M Bauer, and
K W Henne
January 1989,
Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin. Erganzungsband,
R Schulz-Wendtland, and
M Bauer, and
K W Henne
November 1998,
Acta radiologica (Stockholm, Sweden : 1987),
R Schulz-Wendtland, and
M Bauer, and
K W Henne
January 1989,
Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin. Erganzungsband,
